Letter to the editor

Int J Cancer. 2016 Jun 1;138(11):2763-70. doi: 10.1002/ijc.30005. Epub 2016 Feb 21.

Authors

Carmelo Sterrantino^{1

2}, Marco Miroddi^{1

2}, Bob Phillips^{2

3}, Lesley Stewart²

Affiliations

¹ Department of Clinical and Experimental Medicine, University of Messina, Policlinico "G. Martino", Messina, 98125, Italy.
² Centre for Reviews and Dissemination, University of York, York, United Kingdom.
³ Department of Paediatric Oncology Haematology, Leeds General Infirmary, Leeds, United Kingdom.

PMID: 26789636
DOI: 10.1002/ijc.30005

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects*
Antineoplastic Agents / adverse effects*
Humans
Neoplasms / drug therapy*
Neutropenia / chemically induced*

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents

Grants and funding

G0800472/MRC_/Medical Research Council/United Kingdom